Connection

Daniel Steinberg to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Daniel Steinberg has written about Treatment Outcome.
Daniel Steinberg
Connection Strength
0.738
Treatment Outcome
  1. Aortic Diastolic Blood Pressure and Widened Pulse Pressure as Post-Transcatheter Aortic Valve Implantation Measurements. Cardiovasc Revasc Med. 2022 06; 39:26-27.
    View in: PubMed
    Score: 0.085
  2. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud? in patients with stroke or transient ischemic attack. Catheter Cardiovasc Interv. 2015 Jun; 85(7):1262-7.
    View in: PubMed
    Score: 0.052
  3. Advances in transcatheter valve therapies. J Cardiovasc Transl Res. 2014 Jun; 7(4):375-86.
    View in: PubMed
    Score: 0.049
  4. Everolimus-eluting stents in interventional cardiology. Vasc Health Risk Manag. 2012; 8:393-404.
    View in: PubMed
    Score: 0.043
  5. Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. JACC Cardiovasc Interv. 2010 May; 3(5):486-94.
    View in: PubMed
    Score: 0.037
  6. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Am J Cardiol. 2009 Feb 15; 103(4):491-5.
    View in: PubMed
    Score: 0.034
  7. Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris. Am J Cardiol. 2008 Jul 15; 102(2):160-4.
    View in: PubMed
    Score: 0.033
  8. Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries. Am J Cardiol. 2007 Mar 01; 99(5):599-602.
    View in: PubMed
    Score: 0.030
  9. Hemodynamic Impact of MitraClip Procedure for Systemic Tricuspid Regurgitation in Congenitally Corrected Transposition of Great Arteries: A Case Report. Cardiovasc Revasc Med. 2021 07; 28S:114-117.
    View in: PubMed
    Score: 0.019
  10. SCAI expert consensus statement update on best practices for transradial angiography and intervention. Catheter Cardiovasc Interv. 2020 02; 95(2):245-252.
    View in: PubMed
    Score: 0.018
  11. Effects of Percutaneous LVAD Support on Right Ventricular Load and Adaptation. J Cardiovasc Transl Res. 2019 04; 12(2):142-149.
    View in: PubMed
    Score: 0.016
  12. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis. J Cardiovasc Comput Tomogr. 2016 Sep-Oct; 10(5):377-83.
    View in: PubMed
    Score: 0.014
  13. Functioning Cooley-Cutter aortic valve prosthesis 40 years after implantation. J Thorac Cardiovasc Surg. 2014 Mar; 147(3):e21-2.
    View in: PubMed
    Score: 0.012
  14. Recurrent events after percutaneous closure of patent foramen ovale. Catheter Cardiovasc Interv. 2013 Oct 01; 82(4):541-6.
    View in: PubMed
    Score: 0.012
  15. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: outcomes in young, middle-aged, and elderly patients. Catheter Cardiovasc Interv. 2013 Nov 01; 82(5):838-45.
    View in: PubMed
    Score: 0.011
  16. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study. Catheter Cardiovasc Interv. 2013 Feb; 81(2):335-9.
    View in: PubMed
    Score: 0.011
  17. Percutaneous coronary intervention with second-generation paclitaxel-eluting stents versus everolimus-eluting stents in United States contemporary practice (REWARDS TLX Trial). Am J Cardiol. 2012 Oct 15; 110(8):1119-24.
    View in: PubMed
    Score: 0.011
  18. Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry. Catheter Cardiovasc Interv. 2013 Feb; 81(2):348-55.
    View in: PubMed
    Score: 0.011
  19. New onset atrial fibrillation after patent foramen ovale closure. Catheter Cardiovasc Interv. 2009 Nov 15; 74(6):889-95.
    View in: PubMed
    Score: 0.009
  20. Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty. Cardiovasc Revasc Med. 2009 Jul-Sep; 10(3):156-61.
    View in: PubMed
    Score: 0.009
  21. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy. Catheter Cardiovasc Interv. 2009 Jun 01; 73(7):866-70.
    View in: PubMed
    Score: 0.009
  22. Prognostic value of the Syntax score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease. Catheter Cardiovasc Interv. 2009 Apr 01; 73(5):612-7.
    View in: PubMed
    Score: 0.009
  23. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents. Arch Cardiovasc Dis. 2009 Mar; 102(3):209-17.
    View in: PubMed
    Score: 0.009
  24. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries. Am J Cardiol. 2009 Feb 15; 103(4):496-500.
    View in: PubMed
    Score: 0.009
  25. Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice. Arch Cardiovasc Dis. 2009 Feb; 102(2):143-51.
    View in: PubMed
    Score: 0.009
  26. Clinical outcomes after implantation of small diameter (=2.5?mm) sirolimus- versus paclitaxel-eluting stents. Int J Cardiol. 2010 Sep 24; 144(1):105-7.
    View in: PubMed
    Score: 0.009
  27. Impact of bivalirudin use on outcomes in nonagenarians undergoing percutaneous coronary intervention. J Interv Cardiol. 2009 Feb; 22(1):61-7.
    View in: PubMed
    Score: 0.009
  28. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation. Am J Cardiol. 2009 Mar 15; 103(6):801-5.
    View in: PubMed
    Score: 0.009
  29. Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stents. Am J Cardiol. 2009 Mar 01; 103(5):653-8.
    View in: PubMed
    Score: 0.009
  30. Can direct stenting in selected saphenous vein graft lesions be considered an alternative to percutaneous intervention with a distal protection device? Catheter Cardiovasc Interv. 2008 Nov 15; 72(6):799-803.
    View in: PubMed
    Score: 0.008
  31. Comparison of safety, efficacy, and outcome of successful versus unsuccessful percutaneous coronary intervention in "true" chronic total occlusions. Am J Cardiol. 2008 Nov 01; 102(9):1175-81.
    View in: PubMed
    Score: 0.008
  32. Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts. Am J Cardiol. 2008 Sep 01; 102(5):530-4.
    View in: PubMed
    Score: 0.008
  33. Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome. Am J Cardiol. 2008 Sep 01; 102(5):535-40.
    View in: PubMed
    Score: 0.008
  34. Effect of alcohol septal ablation in patients with hypertrophic cardiomyopathy on the electrocardiographic pattern. Am J Cardiol. 2008 Sep 01; 102(5):621-4.
    View in: PubMed
    Score: 0.008
  35. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J. 2008 Aug; 29(15):1851-7.
    View in: PubMed
    Score: 0.008
  36. Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shock. Am J Cardiol. 2008 Aug 01; 102(3):287-91.
    View in: PubMed
    Score: 0.008
  37. Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry). Am J Cardiol. 2008 Aug 01; 102(3):292-7.
    View in: PubMed
    Score: 0.008
  38. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels. Am J Cardiol. 2008 Jun 01; 101(11):1544-9.
    View in: PubMed
    Score: 0.008
  39. Outcomes after sirolimus- and paclitaxel-eluting stent implantation in patients with insulin-treated diabetes mellitus. Am J Cardiol. 2008 May 01; 101(9):1253-8.
    View in: PubMed
    Score: 0.008
  40. Adjunct thrombus aspiration reduces mortality in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction with high-risk angiographic characteristics. Am J Cardiol. 2008 Feb 15; 101(4):452-6.
    View in: PubMed
    Score: 0.008
  41. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction. Cardiovasc Revasc Med. 2008 Jan-Mar; 9(1):24-8.
    View in: PubMed
    Score: 0.008
  42. Does creatine kinase-MB (CK-MB) isoenzyme elevation following percutaneous coronary intervention with drug-eluting stents impact late clinical outcome? Catheter Cardiovasc Interv. 2007 Nov 15; 70(6):826-31.
    View in: PubMed
    Score: 0.008
  43. Angiographic and procedural correlates of stent thrombosis after intracoronary implantation of drug-eluting stents. J Interv Cardiol. 2007 Oct; 20(5):307-13.
    View in: PubMed
    Score: 0.008
  44. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation. 2007 Sep 11; 116(11 Suppl):I200-6.
    View in: PubMed
    Score: 0.008
  45. Comparison between sirolimus- and paclitaxel-eluting stents in complex patient and lesions subsets. Catheter Cardiovasc Interv. 2007 Aug 01; 70(2):167-72.
    View in: PubMed
    Score: 0.008
  46. Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent. Catheter Cardiovasc Interv. 2007 Jul 01; 70(1):9-14.
    View in: PubMed
    Score: 0.008
  47. Sirolimus-eluting stents and calcified coronary lesions: clinical outcomes of patients treated with and without rotational atherectomy. Catheter Cardiovasc Interv. 2006 Dec; 68(6):873-8.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.